GMED(Globus Medical, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $958.10M | $1.02B | $1.57B | $2.52B | $2.94B |
| 毛利润 | $718.88M | $759.12M | $1.02B | $1.48B | $1.98B |
| 营业利润 | $171.95M | $227.95M | $133.14M | $165.99M | $479.82M |
| 净利润 | $149.19M | $190.17M | $122.87M | $102.98M | $537.87M |
| 经营现金流 | $276.27M | $178.47M | $243.50M | $520.64M | $753.45M |
| 自由现金流 | $219.38M | $104.42M | $165.22M | $405.21M | $588.77M |
| 摊薄每股收益 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 |